GENEVA, July 9 -- SHANGHAI ESCUGEN BIOTECHNOLOGY CO., LTD. filed a patent application (CN2026/070816) for “ANTIBODY-DRUG CONJUGATE”. With publication no. WO/2026/145811, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....